(70 days)
Not Found
Not Found
No
The description mentions "computer analysis of these images" but provides no details suggesting the use of AI/ML techniques like deep learning or neural networks. The lack of mention of training/test sets or performance metrics typically associated with AI/ML further supports this.
No.
The device is used for diagnostic purposes (assessing retinal thickness abnormalities and visualizing pathologies) rather than for treating a condition or disease.
Yes
The device is described as being indicated for "assessing the area and location of retinal thickness abnormalities, such as thickening due to macular edema and atrophy associated with degenerative diseases, and for visualizing other retinal pathologies," which are diagnostic purposes.
No
The device description explicitly details hardware components such as laser and conventional light sources, optics, a scanner, and a digital camera, indicating it is a hardware-based system with integrated software for analysis.
Based on the provided information, the RTA 5 & RTA Model E Retinal Thickness Analyzer is not an In Vitro Diagnostic (IVD).
Here's why:
- IVD Definition: In Vitro Diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- RTA 5 & RTA Model E Function: The RTA 5 & RTA Model E is described as a "computerized slitlamp biomicroscope that is intended to provide manual and computerized tomography of the retina in vivo." The term "in vivo" means that the examination is performed on a living organism (in this case, the patient's eye) directly, without taking a sample from the body.
- Method of Operation: The device scans the retina directly using light and optics to determine thickness and structure. It does not analyze biological samples.
Therefore, the RTA 5 & RTA Model E falls under the category of in vivo diagnostic imaging devices rather than In Vitro Diagnostics.
N/A
Intended Use / Indications for Use
The RTA 5 & RTA Model E Retinal Thickness Analyzer ("RTA 5 & RTA Model E") is a computerized slitlamp biomicroscope that is intended to provide manual and computerized tomography of the retina in vivo. The RTA 5 & RTA Model E scans successive slit images on the fundus, without the need for a contact lens, to determine the thickness and the inner structure of the retina, both by observation of the slit images and by computer analysis of these images. It is indicated for assessing the area and location of retinal thickness abnormalities, such as thickening due to macular edema and atrophy associated with degenerative diseases, and for visualizing other retinal pathologies.
Product codes (comma separated list FDA assigned to the subject device)
HLI
Device Description
The RTA 5 & RTA Model E is a computerized electro-optical system comprised of two primary components, namely the optical head and the computer system. The main elements of the optical head include laser and conventional light sources, optics, a scanner, and a digital camera.
The RTA 5 & RTA Model E is a computerized slitlamp biomicroscope that provides manual and computerized tomography of the retina in vivo. The RTA 5 & RTA Model E scans successive slit images of the fundus to determine the thickness and the inner structure of the retina, both by observation of the slit images and by computer analysis of these images. The RTA 5 & RTA Model E uses a solid-state laser source that emits green light at a wavelength of 532 nm. The beam is focused into a thin slit and, by means of a beam-splitter, is directed toward the eye. The scanner and optics then detect the image of the illuminated portion of the retina and transmit the image to the digital camera. The digital camera then captures the image, where it can then be stored and analyzed by the computer system.
Mentions image processing
computerized tomography of the retina in vivo. ... determine the thickness and the inner structure of the retina, both by observation of the slit images and by computer analysis of these images.
The digital camera then captures the image, where it can then be stored and analyzed by the computer system.
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Scanned slit images from a computerized slitlamp biomicroscope.
Anatomical Site
Retina, Fundus
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Talia Technology Ltd.'s RTA Retinal Thickness Analyzer
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 886.1570 Ophthalmoscope.
(a)
Identification. An ophthalmoscope is an AC-powered or battery-powered device containing illumination and viewing optics intended to examine the media (cornea, aqueous, lens, and vitreous) and the retina of the eye.(b)
Classification. Class II (special controls). The device, when it is an AC-powered opthalmoscope, a battery-powered opthalmoscope, or a hand-held ophthalmoscope replacement battery, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 886.9.
0
AUG 2 3 2006
510(k) SUMMARY
Talia Technology, Ltd.'s RTA 5 & RTA Model E Retinal Thickness Analyzer
Contact Information:
| Submitter: | Talia Technology, Ltd.
2 Yodfat Lod, Israel
Phone: 011-972-892-090-40
Facsimile: 011-972-891-510-09
Email: eamoyal@talia.com |
|-----------------------|------------------------------------------------------------------------------------------------------------------------------------------|
| Contact Person: | Mr. Efi Amoyal, QA Manager |
| Name of The Device: | RTA 5 & RTA Model E Retinal Thickness Analyzer |
| Common or Usual Name: | Retinal Thickness Analyzer |
| Classification Name: | Ophtalmoscope, AC-Powered (Product Code HLI) |
| Predicate Devices: | Talia Technology Ltd.'s RTA Retinal Thickness Analyzer |
Intended Use:
The RTA 5 & RTA Model E Retinal Thickness Analyzer ("RTA 5 & RTA Model E") is a computerized slitlamp biomicroscope that is intended to provide manual and computerized tomography of the retina in vivo. The RTA 5 & RTA Model E scans successive slit images on the fundus, without the need for a contact lens, to determine the thickness and the inner structure of the retina, both by observation of the slit images and by computer analysis of these images. It is indicated for assessing the area and location of retinal thickness abnormalities, such as thickening due to macular edema and atrophy associated with degenerative diseases, and for visualizing other retinal pathologies.
Device Description, Principles of Operation, and Technological Characteristics:
The RTA 5 & RTA Model E is a computerized electro-optical system comprised of two primary components, namely the optical head and the computer system. The main elements of the optical head include laser and conventional light sources, optics, a scanner, and a digital camera.
1
The RTA 5 & RTA Model E is a computerized slitlamp biomicroscope that provides manual and computerized tomography of the retina in vivo. The RTA 5 & RTA Model E scans successive slit images of the fundus to determine the thickness and the inner structure of the retina, both by observation of the slit images and by computer analysis of these images. The RTA 5 & RTA Model E uses a solid-state laser source that emits green light at a wavelength of 532 nm. The beam is focused into a thin slit and, by means of a beam-splitter, is directed toward the eye. The scanner and optics then detect the image of the illuminated portion of the retina and transmit the image to the digital camera. The digital camera then captures the image, where it can then be stored and analyzed by the computer system.
Substantial Equivalence:
The RTA 5 & RTA Model E is a modification to the previously cleared RTA Model D Retinal Thickness Analyzer. The only differences between the previously cleared RTA and the modified RTA 5 & RTA Model E are:
-
- An additional scanning procedure was added with the capability to scan 24 sequential positions with overall coverage of 6x3 mm (HxV) on the retina. The basic scan of 16 sequential positions with overall coverage of 3x3 mm (HxV) on the retina was preserved and has not been changed.
-
- Stereo Angle can be set at 9.8° or 5.4°, compared to 12.2° and 7.4°, respectively. in Model D.
-
- Filament Light Illumination the light illumination intensity on the retina was reduced for patient convenience to allow better penetration through a small pupil and an undilated pupil.
-
- Target Mechanism new target mechanism allows grabbing of fundus image without dark pattern artifact on the fundus image.
-
- Human Engineering and External Product Design
-
- Material change for patient contacting materials from C-Flex R70-091 to C-Flex Opaque, both of which are primarily composed of thermoplastic elastomer (TPE).
-
- Software Change
Through design control assessment, including verification and validation testing, Talia has demonstrated that the modifications to the cleared RTA do not raise any new questions of safety or effectiveness. Accordingly, the RTA 5 & RTA Model E is substantially equivalent.
2
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/2/Picture/1 description: The image shows the seal of the Department of Health & Human Services - USA. The seal is circular and contains the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. In the center of the seal is an image of an eagle with its wings spread. The eagle is facing to the right and has three lines representing its feathers.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
AUG 2 3 2006
Talia Technology, Ltd. c/o Jonathan S. Kahan Hohan & Hartson L.L.P. 555 Thirteenth St. N.W. Washington, DC 20004-1109
K061674 Re:
Trade/Device Name: RTA 5 & RTA Model E Retinal Thickness Analyzer Regulation Number: 21 CFR 886.1570 Regulation Name: Ophthalmoscope, AC-Powered Regulatory Class: II Product Code: HLI Dated: August 14, 2006 Received: August 14, 2006
Dear Mr. Kahan:
We have reviewed your Section 510(k) premarket notification of intent to market the device wf nave roviewed your we determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate for ass based of to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The I ou may, dicrerer, mains of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean r toase of actived that I Drimination that your device complies with other requirements of the Act that i Drederal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (21 CFR Part 820); and if applicable, the electronic forth in the quarty by ovisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
3
Page 2 – Jonathan S. Kahan
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
M.B. Eychler SimMD
Malvina B. Eydelman, M.D. Director Division of Ophthalmic and Ear, Nose and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
ATTACHMENT 8
Indications For Use Statement
510(K) Number (if known):
Device Name:
RTA 5 & RTA Model E Retinal Thickness Analyzer
Indications for Use:
The RTA 5 & RTA Model E Retinal Thickness Analyzer ("RTA 5 & RTA Model E") is a computerized slitlamp biomicroscope that is intended to provide manual and computerized tomography of the retina in vivo. The RTA 5 & RTA Model E scans successive slit images on the fundus, without the need for a contact lens, to determine the thickness and the inner structure of the retina, both by observation of the slit images and by computer analysis of these images. It is indicated for assessing the area and location of retinal thickness abnormalities, such as thickening due to macular edema and atrophy associated with degenerative diseases, and for visualizing other retinal pathologies.
Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Denis L. Mc Carthy
(Division Sign-Off)
Division of Ophthalmic Ear,
Nose and Throat Devises
510(k) Number K061674
Page 1 of 1